Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY23 results · Oct–Dec 2022
Metropolis Healthcare reported revenue from operations of ₹285.46 crore (down 2.6% from Q3 FY22) and net profit of ₹35.86 crore (down 13.0% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 285.46 | 293.05 | −2.6% | 300.35 | −5.0% |
| Other income | 6.62 | 2.61 | +153.8% | 4.34 | +52.8% |
| Total income | 292.08 | 295.66 | −1.2% | 304.68 | −4.1% |
| Profit before tax | 47.97 | 56.09 | −14.5% | 54.80 | −12.4% |
| Net profit for the period | 35.86 | 41.22 | −13.0% | 40.48 | −11.4% |
| Attributable to shareholders of the company | 35.80 | 41.04 | −12.8% | 40.33 | −11.2% |
| EPS, basic (₹) | 6.99 | 8.02 | −12.9% | 7.88 | −11.3% |
| Net margin (%) | 12.6 | 14.1 | 13.5 |
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 264.55 | 212.24 | +24.7% | 280.06 | −5.5% |
| Other income | 6.79 | 1.45 | +369.3% | 2.93 | +131.8% |
| Total income | 271.35 | 213.68 | +27.0% | 282.99 | −4.1% |
| Profit before tax | 44.38 | 33.46 | +32.6% | 50.67 | −12.4% |
| Net profit for the period | 32.83 | 24.86 | +32.0% | 37.82 | −13.2% |
| EPS, basic (₹) | 6.41 | 4.86 | +31.9% | 7.39 | −13.3% |
| Net margin (%) | 12.4 | 11.7 | 13.5 |
Consolidated
- Filed with BSE
- 11 Feb 2023, 11:53 IST
- Board meeting
- 10 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2023, 11:53 IST
- Board meeting
- 10 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE